NDC 72162-1813-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1813
- Requested NDC
- 72162-1813-01
- Package NDCs from labels
- 72162-1813-1, 72162-1813-2, 72162-1813-4, 72162-1813-6, 72162-1813-7, 72162-1813-8, 72162-1813-9, 72162-1813-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1813-1 | Gabapentin | 100 in 1 BOTTLE | CAPSULE | 100 | 103 | |
| 72162-1813-2 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 103 | |
| 72162-1813-4 | Gabapentin | 20 in 1 BOTTLE | CAPSULE | 20 | 103 | |
| 72162-1813-6 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 103 | |
| 72162-1813-7 | Gabapentin | 180 in 1 BOTTLE | CAPSULE | 180 | 103 | |
| 72162-1813-8 | Gabapentin | 84 in 1 BOTTLE | CAPSULE | 84 | 103 | |
| 72162-1813-9 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 103 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1813 | GABAPENTIN CAPSULE [BRYANT RANCH PREPACK] | 103 | Current NDC, 7 package rows | 20241122_7b404ab9-8a7e-49d4-920f-487875d14e45.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1813-1 | EA - Each | 72162-1813 | 8856c4e8-137b-44a5-808d-f98066f19826 | 1 | 2023-10-16 |
| 72162-1813-2 | EA - Each | 72162-1813 | a183c871-091d-44cf-9543-d7001ec1c283 | 1 | 2023-10-16 |
| 72162-1813-4 | EA - Each | 72162-1813 | b07e71dd-2f20-45ee-991b-6c6439d04975 | 1 | 2023-10-16 |
| 72162-1813-6 | EA - Each | 72162-1813 | 9e445edb-c461-4927-b6b3-e05adc58973d | 1 | 2023-10-16 |
| 72162-1813-7 | EA - Each | 72162-1813 | c96e5a2f-b40c-487c-ba7d-b9d07d0426c2 | 1 | 2023-10-16 |
| 72162-1813-8 | EA - Each | 72162-1813 | 67d0ac8a-2d12-4499-a0a3-e52e90e6285b | 1 | 2023-10-16 |
| 72162-1813-9 | EA - Each | 72162-1813 | ab614c8e-b9c9-4442-bd0b-61e9a0f3be0e | 1 | 2023-10-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | b2da7d96-73ad-4f44-8784-160a384a0961 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | f93eaa4f-cc1a-10ab-e053-6394a90a5ffc | 2026-06-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | f8998c1c-c359-6f01-e053-6294a90aebf4 | 2026-06-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| gabapentin | GABAPENTIN | Proficient Rx LP | c7674ea5-276b-4bb3-821b-4ac05c9e64e6 | 2026-06-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 507bf6d0-e7a2-413d-9848-cd2445a1411d | 2026-05-30 | Warnings, Adverse reactions | ANDA078428 65162-102 310430 310432 310431 385f01e9-5b50-41d8-a2d5-748f5f84c027 507bf6d0-e7a2-413d-9848-cd2445a1411d 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Laurus Labs Limited | 07aa1bcc-df05-44fa-92d4-63894e0e6cd6 | 2026-05-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 03031adf-d36b-45ec-944e-dfce5a5de91a | 2026-05-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Pangea Pharmaceuticals, LLC | 5eff7ad8-0d31-4372-82a2-ac9f549d8796 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 397fd6d3-317b-4b61-a52b-3a09ca1d88a4 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 13640281-26b4-402e-8f69-7c81cd6e0376 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amici Pharma, Inc. | 1ea83c18-7107-41f4-8305-62725c1c45c8 | 2026-05-19 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | d4f21e97-5e55-44c9-9b31-5f79ac2eb512 | 2026-05-18 | Warnings, Adverse reactions | 310430 310431 6CW7F3G59X |
| Neurontin | GABAPENTIN | Viatris Specialty LLC | 97935fd9-1d4a-43b6-a5d9-de994591187b | 2026-05-12 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | eeb19a5a-b31d-4df8-9546-0b2b5eb5db07 | 2026-05-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 152adf1d-ec0c-4561-bf80-e4c7da158723 | 2026-05-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 999f3685-2eac-467e-bed2-1d0c36aaf0ed | 2026-05-04 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee | 2026-05-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 35da078b-0da0-4757-a6c4-a9144c37e8e1 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Preferred Pharmaceuticals Inc. | 38119f2e-33b3-4c3c-99b7-9335d8d280d4 | 2026-05-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b8b7e045-a7fe-8539-e053-2a95a90a40f8 | 2026-05-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.